Skip to main content

Table 6 Studies reporting effectiveness and measurement of effectiveness of levomepromazine

From: Evidence for the use of Levomepromazine for symptom control in the palliative care setting: a systematic review

Indication

Reference

Number of patients under study

Number of patients receiving levomepromazine

Effect

sedation

Alonso-Babarro [31]

29

2

100% (defined as symptom control was achieved, consciousness (consciousness was 5 or greater using the Ramsay scale and no emergency calls during the PS process)

nausea

Eisenchlas [13]

70

70

86% (categorized as responders if NRS score decreased by 6+ from the baseline score)

nausea

Kennett [50]

65

65

62.3% (14 patients met the definition of a complete response and 19 a partial response)

nausea

Higi [51]

113

113

62% (fully protected from nausea and vomiting)

nausea

Oliver [41]

675

15

86% (no data about how effectiveness was measured)

nausea

Twycross [55]

29

29

83% (no data about how effectiveness was measured, study not included in our review)

delirium

Fainsinger [38]

1

1

0% (ineffective in treating the patient’s delirium and thus discontinued after 48 hours)

agitation

Oliver [41]

675

49

67% (no data about how effectiveness was measured)

pain

Oliver [41]

675

16

94% (no data about how effectiveness was measured)